News: Archives
Miller School Sports Medicine Researcher Calls for Caution in Using PRP or Stem Cells to Treat Young Athletes’ Injuries 05.17.2017
Physicians, parents and coaches should be cautious when considering treating injured young athletes with platelet rich plasma (PRP), stem cells or other types of regenerative medicine, says a nationally recognized sports medicine clinician and researcher at the University of Miami Miller School of Medicine and UHealth Sports Medicine Institute.
Miller School Research Shows Epicardial Fat is a Modifiable Risk Factor for Type 2 Diabetics 05.15.2017
Research by Gianluca Iacobellis, M.D., Ph.D., professor of clinical medicine in the Division of Endocrinology, Diabetes and Metabolism at the University of Miami Miller School of Medicine, has shown that a drug commonly prescribed for patients with type 2 diabetes can significantly reduce epicardial adipose tissue, the fat around and within the heart.
Pediatric Pulmonologist Andrew Colin to Receive Prestigious Award 05.15.2017
“Likely the equivalent of an Oscar in our field,” being nominated by his peers for the Lifetime Contributions to Pediatric Respiratory Medicine Award means a great deal to Andrew Colin, M.D., Director of the Division of Pediatric Pulmonary Medicine at the University of Miami Miller School of Medicine.
51st Miami Winter Symposium Will Focus on Stem Cells 05.15.2017
The 51st Miami Winter Symposium, to be held January 28-31, 2018, at the Hyatt Regency in Miami, will focus entirely on stem cells. Expert international speakers will give invited plenary talks supplemented by 12 selected ‘Spotlight’ talks and a large poster session.
Miller School Class of 2017 Celebrates a Spectacular Commencement 05.11.2017
“Congratulations, Doctors!” University of Miami President Julio Frenk called out as the 196 graduating members of the Miller School of Medicine Class of 2017 marched to the stage Wednesday night to be hooded by their teachers and mentors, receive their diplomas, and exult in the cheers and applause of their family and friends.
Department of Dermatology and Cutaneous Surgery Holds First Annual Research Day 05.11.2017
The University of Miami Miller School of Medicine’s Department of Dermatology and Cutaneous Surgery hosted its first annual Celia & Samuel Resnik Research Day on May 6, featuring scientific achievements of faculty and trainees. The event, which took place at the Shalala Student Center on the Coral Gables campus, included 50 presentations, a graduation ceremony for 11 fellows, and scientific poster sessions.
Student Researcher Owen Tan Named 2017 St. Baldrick’s Summer Fellow 05.11.2017
To support his research at Sylvester Comprehensive Cancer Center, Owen Tan, a student at the University of Miami Miller School of Medicine, has been awarded a $5,000 summer fellowship grant from the St. Baldrick’s Foundation. The Miller School is one of only 21 institutions in the U.S. — and the only one in Florida — to receive a grant. Tan plans to use his to support his research into pediatric brain tumors.
University of Miami Hospital Implements State-of-the-Art Electronic Medical Record System 05.11.2017
University of Miami Hospital is significantly transforming its patient care experience by upgrading its electronic medical record (EMR) system to UChart. The upgrade will positively impact patients and the entire University of Miami Health System community, and once completed in October it will mark the final phase of the University’s creation of a true enterprise-level EMR.
Health Care Hero Dr. Eugene Schiff Wins Lifetime Achievement Award 05.10.2017
The University of Miami Health System and Miller School of Medicine have enjoyed great success at the Greater Miami Chamber of Commerce’s Health Care Heroes awards. Eugene R. Schiff, M.D., received the AXA Advisors Lifetime Achievement Award for his work in hepatology.
Research Findings Show Tissue-Engineered Islet Transplant Achieves Insulin Independence 05.10.2017
Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have produced the first clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered platform can successfully engraft and achieve insulin independence in type 1 diabetes. The findings were published in the May 11 issue of the New England Journal of Medicine.